Tencent-Backed AI Drug Researcher Xtalpi's Shares Double On Revenue Rise

Full Article
Tencent-Backed AI Drug Researcher Xtalpi's Shares Double On Revenue Rise

Xtalpi, a Shenzhen-based AI drug discovery company, experienced a remarkable 108% increase in its stock price on the Hong Kong stock exchange, elevating its market capitalization to $5.5 billion. This surge followed the company's announcement of a 28% year-over-year revenue growth, reaching 102.6 million yuan ($14.4 million) in the first half of 2024. A significant factor in this growth was a partnership with GCL Group, valued at over $135 million, aimed at developing new materials for lithium-ion batteries.

Despite the impressive revenue growth, Xtalpi reported a widening net loss of 1.3 billion yuan, attributed to increased expenses and reduced interest income. The company continues to invest heavily in research and development, spending 210.4 million yuan in the first half of the year. Xtalpi's innovative approach combines AI, quantum physics, and cloud computing to discover new drug candidates, showcasing its commitment to advancing healthcare solutions.

• Xtalpi's stock price surged 108% after reporting significant revenue growth.

• The company secured a $135 million partnership with GCL Group for battery research.

Key AI Terms Mentioned in this Article

AI Drug Discovery

Xtalpi employs AI to enhance its drug discovery processes, leading to increased customer engagement and revenue growth.

Quantum Computing

Xtalpi integrates quantum computing with AI to discover novel drug candidates.

Machine Learning

Xtalpi's AI-powered services leverage machine learning to optimize drug discovery.

Companies Mentioned in this Article

Xtalpi

Xtalpi's innovative approach has attracted significant investment and partnerships, enhancing its market position.

GCL Group

GCL Group's partnership with Xtalpi aims to advance research in battery technology.

Get Email Alerts for AI News

By creating an email alert, you agree to AIleap's Terms of Service and Privacy Policy. You can pause or unsubscribe from email alerts at any time.

Latest Articles

Alphabet's AI drug discovery platform Isomorphic Labs raises $600M from Thrive
TechCrunch 6month

Isomorphic Labs, the AI drug discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital for the first time. The $600

AI In Education - Up-level Your Teaching With AI By Cloning Yourself
Forbes 6month

How to level up your teaching with AI. Discover how to use clones and GPTs in your classroom—personalized AI teaching is the future.

Trump's Third Term - How AI Can Help To Overthrow The US Government
Forbes 6month

Trump's Third Term? AI already knows how this can be done. A study shows how OpenAI, Grok, DeepSeek & Google outline ways to dismantle U.S. democracy.

Sam Altman Says OpenAI Will Release an 'Open Weight' AI Model This Summer
Wired 6month

Sam Altman today revealed that OpenAI will release an open weight artificial intelligence model in the coming months. "We are excited to release a powerful new open-weight language model with reasoning in the coming months," Altman wrote on X.

Popular Topics